Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1992 Feb;66(2):1162–1170. doi: 10.1128/jvi.66.2.1162-1170.1992

A novel particulate influenza vaccine induces long-term and broad-based immunity in mice after oral immunization.

G T Pang 1, R L Clancy 1, S E O'Reilly 1, A W Cripps 1
PMCID: PMC240820  PMID: 1731094

Abstract

The immunogenicity of a novel particulate oral influenza vaccine was examined in terms of antibody response and protection in mice. Oral immunization with chicken erythrocytes (CRBC) adsorbed with gamma-irradiated influenza A virus induced high levels of immunoglobulin G antibodies and protection in the lung compared with gamma-irradiated virus administered alone or CRBC. Immunoglobulin A antibodies were the predominant antibodies in nasal washings, and their presence did not correlate with protection as well as immunoglobulin G antibodies. Immunity was not specific for the immunizing virus subtype, as antibodies and enhanced lung clearance of virus were demonstrated with different virus subtypes. However, mice were not protected when challenged with live influenza B virus. The antibody response and the degree of protection were dependent on both the concentration of virus adsorbed to CRBC and number of CRBC adsorbed to virus. Virus-adsorbed CRBC given subcutaneously failed to induce antibodies or protection. Oral immunization with A/Qld/6/72 (H3N2) virus gave a high level of protection over 12 weeks, which could be demonstrated with different subtypes. Protection correlated with antibody levels in the lung determined by both enzyme-linked immunosorbent and hemagglutination inhibition assays, although the levels detected by the latter declined over time.

Full text

PDF
1162

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balkovic E. S., Six H. R. Pulmonary and serum isotypic antibody responses of mice to live and inactivated influenza virus. Am Rev Respir Dis. 1986 Jul;134(1):6–11. doi: 10.1164/arrd.1986.134.1.6. [DOI] [PubMed] [Google Scholar]
  2. Bergmann K. C., Waldman R. H., Tischner H., Pohl W. D. Antibody in tears, saliva and nasal secretions following oral immunization of humans with inactivated influenza virus vaccine. Int Arch Allergy Appl Immunol. 1986;80(1):107–109. doi: 10.1159/000234034. [DOI] [PubMed] [Google Scholar]
  3. Chen K. S., Burlington D. B., Quinnan G. V., Jr Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccine. J Virol. 1987 Jul;61(7):2150–2154. doi: 10.1128/jvi.61.7.2150-2154.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Clements M. L., Betts R. F., Tierney E. L., Murphy B. R. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J Clin Microbiol. 1986 Jul;24(1):157–160. doi: 10.1128/jcm.24.1.157-160.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Clements M. L., Murphy B. R. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. J Clin Microbiol. 1986 Jan;23(1):66–72. doi: 10.1128/jcm.23.1.66-72.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Eldridge J. H., Gilley R. M., Staas J. K., Moldoveanu Z., Meulbroek J. A., Tice T. R. Biodegradable microspheres: vaccine delivery system for oral immunization. Curr Top Microbiol Immunol. 1989;146:59–66. doi: 10.1007/978-3-642-74529-4_6. [DOI] [PubMed] [Google Scholar]
  7. Farag-Mahmod F. I., Wyde P. R., Rosborough J. P., Six H. R. Immunogenicity and efficacy of orally administered inactivated influenza virus vaccine in mice. Vaccine. 1988 Jun;6(3):262–268. doi: 10.1016/0264-410x(88)90222-8. [DOI] [PubMed] [Google Scholar]
  8. Hirabayashi Y., Kurata H., Funato H., Nagamine T., Aizawa C., Tamura S., Shimada K., Kurata T. Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination. Vaccine. 1990 Jun;8(3):243–248. doi: 10.1016/0264-410x(90)90053-o. [DOI] [PubMed] [Google Scholar]
  9. Ishizaka S., Yoshikawa M., Kitagami K., Tsujii T. Oral adjuvants for viral vaccines in humans. Vaccine. 1990 Aug;8(4):337–341. doi: 10.1016/0264-410x(90)90091-y. [DOI] [PubMed] [Google Scholar]
  10. Johnson P. R., Feldman S., Thompson J. M., Mahoney J. D., Wright P. F. Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J Infect Dis. 1986 Jul;154(1):121–127. doi: 10.1093/infdis/154.1.121. [DOI] [PubMed] [Google Scholar]
  11. Johnson P. R., Jr, Feldman S., Thompson J. M., Mahoney J. D., Wright P. F. Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine. J Med Virol. 1985 Dec;17(4):325–335. doi: 10.1002/jmv.1890170405. [DOI] [PubMed] [Google Scholar]
  12. Jones P. D., Ada G. L. Persistence of influenza virus-specific antibody-secreting cells and B-cell memory after primary murine influenza virus infection. Cell Immunol. 1987 Oct 1;109(1):53–64. doi: 10.1016/0008-8749(87)90291-7. [DOI] [PubMed] [Google Scholar]
  13. Jones P. D., Tha Hla R., Morein B., Lovgren K., Ada G. L. Cellular immune responses in the murine lung to local immunization with influenza A virus glycoproteins in micelles and immunostimulatory complexes (iscoms). Scand J Immunol. 1988 Jun;27(6):645–652. doi: 10.1111/j.1365-3083.1988.tb02397.x. [DOI] [PubMed] [Google Scholar]
  14. Liew F. Y., Russell S. M., Appleyard G., Brand C. M., Beale J. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur J Immunol. 1984 Apr;14(4):350–356. doi: 10.1002/eji.1830140414. [DOI] [PubMed] [Google Scholar]
  15. Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol. 1987 Jul;7(4):265–276. doi: 10.1007/BF00915547. [DOI] [PubMed] [Google Scholar]
  16. Moldoveanu Z., Staas J. K., Gilley R. M., Ray R., Compans R. W., Eldridge J. H., Tice T. R., Mestecky J. Immune responses to influenza virus in orally and systemically immunized mice. Curr Top Microbiol Immunol. 1989;146:91–99. doi: 10.1007/978-3-642-74529-4_10. [DOI] [PubMed] [Google Scholar]
  17. Mowat A. M., Donachie A. M., Reid G., Jarrett O. Immune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route. Immunology. 1991 Mar;72(3):317–322. [PMC free article] [PubMed] [Google Scholar]
  18. Müllbacher A., Ada G. L., Hla R. T. Gamma-irradiated influenza A virus can prime for a cross-reactive and cross-protective immune response against influenza A viruses. Immunol Cell Biol. 1988 Apr;66(Pt 2):153–157. doi: 10.1038/icb.1988.19. [DOI] [PubMed] [Google Scholar]
  19. Tannock G. A., Paul J. A., Barry R. D. Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens. Infect Immun. 1984 Feb;43(2):457–462. doi: 10.1128/iai.43.2.457-462.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Weisz-Carrington P., Grimes S. R., Jr, Lamm M. E. Gut-associated lymphoid tissue as source of an IgA immune response in respiratory tissues after oral immunization and intrabronchial challenge. Cell Immunol. 1987 Apr 15;106(1):132–138. doi: 10.1016/0008-8749(87)90156-0. [DOI] [PubMed] [Google Scholar]
  21. Wright P. F., Murphy B. R., Kervina M., Lawrence E. M., Phelan M. A., Karzon D. T. Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory. Infect Immun. 1983 Jun;40(3):1092–1095. doi: 10.1128/iai.40.3.1092-1095.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES